Abstract
We have studied the effect of membrane structural alteration on the cellular association of the anticancer drug mitoxantrone whose uptake is not carrier-mediated. Membrane fatty acids of L1210 cells were modified by incubating the cells with the highly unsaturated docosahexaenoic acid (22∶6), which results in isolated plasma membranes with 37% of the fatty acids as 22∶6, or with the monounsaturated oleic acid (18∶1), which results in 58% of the fatty acids as 18∶1. The rate of uptake by 22∶6-enriched cells during the first min was 62% greater than by those enriched with 18∶1. The higher rate was recorded at 0.5–16 μM, pH 6.6–7.6 and temperatures 10–40 C. The difference in cell-associated drug apparently was not due simply to a change in mitoxantrone solubility as measured by partitioning of the drug in lipophilic-hydrophilic systems containing lipids from the fatty-acid altered cells. We conclude that the type of fatty acids contained in L1210 cell membranes can affect the cell association of mitoxantrone. This effect could be on transmembrane flux or be due to differences in binding of the drug to intracellular structures.
Similar content being viewed by others
References
Demel, R.A., Guerts van Kessel, W.S.M., and van Deenen, L.L.M. (1972)Biochim. Biophys. Acta 266, 26–40.
Bruns, C.P., and Spector, A.A. (1987)Lipids 22, 178–184.
Burns, C.P., Haugstad, B.N., and North, J.A. (1987)Biochem. Pharmacol. 36, 857–860.
Zee-Cheng, R.K.Y., and Cheng, C.C. (1978)J. Med. Chem. 21, 291–294.
Murdock, K.C., Child, R.G., Fabio, P.F., Angier, R.B., Wallace, R.E., Burr, F.E., and Citarella, R.V. (1979)J. Med. Chem. 22, 1024–1030.
Kapuscinski, J., Darzynkiewicz, Z., Traganos, F., and Melamed, M.R. (1981)Biochem. Pharm. 30, 231–240.
Bowden, G.T., Roberts, R., Alberts, D.S., Peng, Y., and Garcia, D. (1985)Cancer Res. 45, 4915–4920.
Kapuscinski, J. and Darzynkiewicz, Z. (1986)Proc. Natl. Acad. Sci. USA 83, 6302–6306.
Alberts, D.S., Peng, Y.M., Bowden, G.T., Dalton, W.S., and Mackel, C. (1985)Inv. New Drugs 3, 101–107.
Guffy, M.M., North, J.A., and Burns, C.P. (1984)Cancer Res. 44, 1863–1866.
Guffy, M.M., Rosenberger, J.A., Simon, I., and Burns, C.P. (1982)Cancer Res. 42, 3625–3630.
Kaduce T.L., Awad, A.B., Fontenelle, L.J. and Spector, A.A. (1977)J. Biol. Chem. 252, 6624–6630.
Burns, C.P., Luttenegger, D.G., Dudley, D.T., Buettner, G.R., and Spector, A.A. (1979)Cancer Res. 39, 1726–1732.
Hyman, B.T., and Spector, A.A. (1982)J. Neurochem. 38, 650–656.
Yorek, M.A., Strom, D.K., and Spector, A.A. (1984)J. Neurochem. 42, 254–261.
Peng, Y.M., Ormberg, D., Alberts, D.S., and Davis, T.P. (1982)J. Chromatogr. 233, 235–247.
Burns, C.P., and Duddley, D.T. (1982)Biochem. Pharmacol. 31, 2116–2119.
Burns, C.P., and North, J.A. (1986),Biochim. Biophys. Acta 888, 10–17.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951)J. Biol. Chem. 193, 265–275.
Kessel, D. (1979)Biochem. Pharm. 28, 3028–3030.
Duarte-Karim, M., Ruysschaert, J.M., and Hildebrand, J. (1976)Biochem. Biophys. Res. Commun. 71, 658–663.
Tsai, C-M., Chen, K.-Y., and Canellakis, E.S. (1975)Biochim. Biophys. Acta 401, 196–212.
Yang, C.H., Peterson, R.H.F., Sirotnak, F.M., and Chello, P.L. (1979)J. Biol. Chem. 254, 1402–1407.
Avruch, J., and Wallach, D.F.H. (1971)Biochim. Biophys. Acta 233, 334–347.
Folch, J., Lees, M., and Sloane Stanley, G.H. (1957)J. Biol. Chem. 226, 497–509.
Abell, L.L., Levy, B.B., Brodie, B.B., and Kendall, F.E. (1952)J. Biol. Chem. 195, 357–366.
Morrison, W.R., and Smith, L.M. (1964)J. Lipid Res. 5, 600–608.
Skovsgaard, T., and Nissen, N.I. (1982)Pharmac. Ther. 18, 293–311.
Siegfried, J.M., Burke, T.G., and Tritton, T.R. (1985)Biochem. Pharm. 34, 593–598.
Johnson, B.A., Cheang, M.S., and Goldenberg, G.J. (1986)Cancer Res., 46, 218–223.
Taylor, R.F., Teague, L.A., and Yesair, D.W. (1981)Cancer Res. 41, 4316–4123.
Schafer, J.A. and Barfuss, D.W. (1986) inMembrane Transport of Antineoplastic Agents (Goldman, I.D., ed.), pp. 1–37, Pergamon Press, Oxford.
Lieb, W.R., and Stein, W.D. (1986)J. Membrane Biol. 92, 111–119.
Author information
Authors and Affiliations
About this article
Cite this article
Burns, C.P., Haugstad, B.N., Mossman, C.J. et al. Membrane lipid alteration: Effect on cellular uptake of mitoxantrone. Lipids 23, 393–397 (1988). https://doi.org/10.1007/BF02535508
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535508